|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/19 | |
| A61K 38/12 |
| (11) | Patento numeris | 3054924 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14780863.8 |
| Europos patento paraiškos padavimo data | 2014-10-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-08-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/071302 |
| Data | 2014-10-06 |
| (87) | Numeris | WO 2015/052115 |
| Data | 2015-04-16 |
| (30) | Numeris | Data | Šalis |
| 13187612 | 2013-10-07 | EP | |
| 14155993 | 2014-02-20 | EP | |
| 14162110 | 2014-03-27 | EP |
| (72) |
CUBEL SUŃÉ, N ria, ES
|
| (73) |
Centrient Pharmaceuticals Netherlands B.V.,
Alexander Fleminglaan 1, 2613 AX Delft,
NL
Galenicum Health S.L.U., Avinguda de Cornellą 144, 7th floor, 08950 Esplugues de Llobregat, ES |
| (54) | STABLE PHARMACEUTICAL FORMULATIONS OF CASPOFUNGIN |
| STABLE PHARMACEUTICAL FORMULATIONS OF CASPOFUNGIN |